OTRNQualitativeGastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates2018

Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study.

Lea Ladegaard Grønkjær, Thomas Hoppe Sehstedt, Annelise Norlyk and 1 others

PMID 28759517

WHAT IT FOUND

Eight cirrhosis patients described overt hepatic encephalopathy as terrifying and repeatedly disruptive: they lost memory, communication, independence, and social participation, then feared recurrence and felt like burdens.

Nurses and OTs should expect anxiety, dependency, and isolation after episodes.

Key findings

01The analysis identified four interrelated themes: multiple losses, anxiety, dependency on others, and social isolation.

02During episodes, patients lost communication skills and could not express their needs.

03Patients were afraid of recurrence and wanted to know what had happened during the episode.

STILL TO COME

How it was doneWhat they foundWhat it means for OTsWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Only eight patients from one university hospital were interviewed, so the themes cannot be generalized. Participants were interviewed soon after agreeing, at the hospital or outpatient clinic, and some responses may have been affected by recall bias or difficulty separating different episodes. The study did not test any intervention, so it cannot show whether education, medication, or support changes these experiences. Some patients were receiving lactulose, rifaximin, or branched-chain amino acids at the same time, so the contribution of any treatment cannot be separated.

The easy way to misread this

Do not read these themes as proof that any intervention improved or prevented HE. Only eight patients from one hospital were interviewed, and some were receiving lactulose, rifaximin, or branched-chain amino acids together, so the study describes experience, not treatment effect.

Read it on PubMed →